BioSpace News Archive

ADMA Biologics, Inc. today announced that it will report second quarter financial results on August 9, 2023, after the U.S. financial markets close.

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, today announced its financial results for the quarter ended on June 30, 2023.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced financial results for the second quarter ended June 30, 2023 and highlighted recent corporate developments.

Theriva™ Biologics today announced key progress in VIRAGE, a multinational, Phase 2b, randomized, open-label, controlled clinical trial evaluating VCN-01 in combination with standard-of-care chemotherapy (gemcitabine/nab-paclitaxel) as a first-line therapy for patients with metastatic pancreatic ductal adenocarcinoma (PDAC).

Surface Oncology today reported financial results and corporate highlights for the second quarter 2023.

BioCardia®, Inc. today announced it will report its financial results for the three and six months ended June 30, 2023 and provide a corporate update by conference call on Wednesday, August 9, 2023 at 4:30 PM ET.

Ardelyx, Inc. today reported financial results for the second quarter ended June 30, 2023 and provided a business update.

Cryoport, Inc. today announced that the Company will report financial results for the second quarter ended June 30, 2023 on Wednesday, August 9, 2023 after U.S. markets close.

RVL Pharmaceuticals plc today announced that the Company will release its second quarter 2023 financial results and provide a commercial update on Monday, August 14, 2023, before U.S. financial markets open.

Alnylam Pharmaceuticals, Inc. announced today that management will present a company overview at the Canaccord Genuity 43rd Annual Growth Conference on Thursday, August 10, 2023 at 10:30 am ET at the InterContinental Hotel in Boston.